Forte Biosciences FBRX Q1 2026 Results Fall Short EPS 124 Revenue NA The Great TradeDown How Consumers Navigate the Spending Paradox Amid Persistent Inflation Lexeo Therapeutics LXEO Climbs 1049 Resistance at 520 in Focus 20260520 Intelligent INBS Slips 1018 Testing 281 Support 20260520 ImmunoTech AIM Stock Analysis Climbs 414 Eyes on 045 20260520 Equity Residential Stock What Are Wall Street Analysts Saying Lyft LYFT Trading at 1323 Key Decision Point 20260520